Cognitive and motor control in neurofibromatosis type I: Influence of maturation and hyperactivity-inattention

Developmental Neuropsychology

Volumn 35, Issue 6, 2010, Pages 737-751

  Huijbregts, Stephan ^a   Swaab, Hanna ^a   De Sonneville, Leo ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; COGNITION; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INHIBITION (PSYCHOLOGY); MALE; MOTOR ACTIVITY; NEUROFIBROMATOSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; COGNITION; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INHIBITION (PSYCHOLOGY); MALE; MOTOR ACTIVITY; NEUROFIBROMATOSIS 1; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 78149260543     PISSN: 87565641     EISSN: None     Source Type: Journal    
DOI: 10.1080/87565641.2010.508670     Document Type: Article

References (48)

1. Badre, D. (2008). Cognitive control, hierarchy, and the rostro-causdal organization of the frontal lobes. Trends in Cognitive Sciences, 12, 193-200.
2. Barton, B., & North, K. (2004). Social skills of children with Neurofibromatosis Type 1. Developmental Medicine & Child Neurology, 46, 553-563.
3. Bourdon, K. H., Goodman, R., Rae, D. S., Simpson, G., & Koretz, D. S. (2005). The Strengths and Difficulties Questionnaire: U. S. normative data and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 557-564.
4. Bunge, S. A. (2004). How we use rules to select actions: A review of evidence from cognitive neuroscience. Cognitive and Affective Behavioral Neuroscience, 4, 564-579.
5. Clements-Stephans, A. M., Rimrodt, S. L., Gaur, P., & Cutting, L. E. (2008). Visuospatial processing in children with Neurofibromatosis Type 1. Neuropsychologia, 46, 690-697.
6. Crone, E. A., Wendelken, C., Donohue, S., Van Leijenhorst, L., & Bunge, S. A. (2006). Neurocognitive development of the ability to manipulate information in working memory. Proceedings of the National Academy of Sciences USA, 103, 9315-9320.
7. Cutting, L. E., Clements, A. M., Lightman, A. D., Yerby-Hammack, P. D., & Denckla, M. B. (2004). Cognitive profile of Neurofibromatosis Type 1: Rethinking nonverbal learning disabilities. Learning Disabilities Research & Practice, 19, 155-165.
8. Cutting, L. E., Cooper, K. L., Koth, C. W., Mostofsky, S. H., Kates, W. R., Denckla, M. B., et al. (2002). Megalencephaly in NF1: Predominantly white matter contribution and mitigation by ADHD. Neurology, 59, 1388-1394.
9. Descheemaeker, M. J., Ghesquière, P., Symons, H., Fryns, J. P., & Legius, E. (2005). Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis Type 1 Children. Journal of Intellectual Disabilities Research, 49, 33-46.
10. De Sonneville, L. M. J. (1999). Amsterdam neuropsychological tasks: A computer aided assessment programme. In B. P. L. M. Den Brinker, P. J. Beek, A. N. Brand, F. J. Maarse, and L. J. M. Mulder (Eds.), Cognitive ergonomics, clinical assessment and computer assisted learning: computers in psychology (pp. 187-203). Lisse, The Netherlands: Swets and Zeitlinger.
11. Durston, S., Hulshoff-Pol, H. E., Schnack, H. G., Buitelaar, J. K., Steenhuis, M. P., Minderaa, R. B., Kahn, R. S., et al. (2004). Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 332-340.
12. Feldmann, R., Denecke, J., Grenzebach, M., Schuierer, G., & Weglage, J. (2003). Neurofibromatosis Type 1: Motor and cognitive function and T2-weighted MRI hyperintensities. Neurology, 61, 1725-1728.
13. Fisch, G. S., Carpenter, N., Howard-Peebles, P. N., Holden, J. J. A., Tarleton, J., Simensen, R., & Nance, W. (2007). Studies of age-correlated features of cognitive-behavioral development in children and adolescents with genetic disorders. American Journal of Medical Genetics Part A, 143, 2478-2489.
14. Friedman, J. M. (1999). Epidemiology of Neurofibromatosis Type 1. American Journal of Medical Genetics, 89, 1-6.
15. Goodman, R. (1997). The Strengths and Difficulties Questionnaire: A research note. Journal of Child Psychology and Psychiatry, 38, 581-586.
16. Goodman, R. (2001). Psychometric properties of the Strengths and Difficulties Questionaire. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1337-1345.
17. Greenwood, R. S., Tupler, L. A., Whitt, J. K., Buu, A., Dombeck, C. B., Harp, A. G., et al. (2005). Brain morphometry, T2-weighted hyperintensities, and IQ in children with Neurofibromatosis Type 1. Archives of Neurology, 62, 1904-1908.
18. Huijbregts, S. C. J., De Sonneville, L. M. J., Van Spronsen, F. J., Licht, R., & Sergeant, J. A. (2002a). The neuropsychological profile of early-and continuously treated phenylketonuria: Selective attention, vigilance, and "maintenance" versus "manipulation"-functions of working memory. Neuroscience & Biobehavioral Reviews, 26, 697-712.
19. Huijbregts, S. C. J., De Sonneville, L. M. J., Licht, R., Van Spronsen, F. J., & Sergeant, J. A. (2002b). Short-term dietary interventions in children and adolescents with treated phenylketonuria: Effects on neuropsychological outcome of a well-controlled population. Journal of Inherited Metabolic Disease, 25, 419-430.
20. Huijbregts, S., De Sonneville, L., Licht, R., Sergeant, J., & Van Spronsen, F. J. (2002c). Inhibition of prepotent responding and attentional flexibility in treated Phenylketonuria. Developmental Neuropsychology, 22, 481-499.
21. Huijbregts, S. C. J., De Sonneville, L. M. J., Van Spronsen, F. J., Berends, I. E., Licht, R., Verkerk, P. H., et al. (2003). Motor function under lower and higher controlled processing demands in early and continuously treated Phenylketonuria. Neuropsychology, 17, 369-379.
22. Huijbregts, S. C. J., Warren, A. J., De Sonneville, L. M. J., & Swaab-Barneveld, H. (2008). Hot and cool forms of inhibitory control and externalizing behavior in children of mothers who smoked during pregnancy: An exploratory study. Journal of Abnormal Child Psychology, 36, 323-333.
23. Hyman, S. L., Gill, D. S., Shores, E. A., Steinberg, A., & North, K. N. (2007). T2-hyperintensities in children with Neurofibromatosis Type 1 and their relationship to cognitive functioning. Journal of Neurology, Neurosurgery, & Psychiatry, 78, 1088-1091.
24. Hyman, S. L., Gill, D. S., Shores, E. A., Steinberg, E. A., Joy, P., Gibikote, S. V., et al. (2003). Natural history of cognitive deficits and their relationship to MRI T2 hyperintensities in NF1. Neurology, 60, 1139-1145.
25. Hyman, S. L., Shores, A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with Neurofibromatosis Type 1. Neurology, 65, 1037-1044.
26. Hyman, S. L., Shores, E. A., & North, K. N. (2006). Learning disabilities in children with Neurofibromatosis Type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 48, 973-977.
27. Levine, T. M., Materek, A., Abel, J., O'Donnell, M., & Cutting, L. E. (2006). Cognitive profile of Neurofibromatosis Type 1. Seminars in Pediatric Neurology, 13, 8-20.
28. Lorch, M., Ferner, R., Golding, J., & Whurr, R. (1999). The nature of speech and language impairment in adults with Neurofibromatosis 1. Journal of Neurolinguistics, 12, 157-165.
29. Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in Neurofibromatosis Type I. Developmental Medicine & Child Neurology, 44, 164-170.
30. Moore III, B. D., & Denckla, M. B. (2000). Neurofibromatosis. In K. O. Yeates, D. Ris, & H. G. Taylor (Eds.), Textbook of pediatric neuropsychology: Research, theory, and practice (1st ed., pp. 149-170). New York: Guildford Press.
31. Moore, B. D., III, Slopis, J. M., Jackson E. F., De Winter, A. E., & Leeds N. E. (2000). Brain volume in children with Neurofibromatosis Type 1: Relation to neuropsychological status. Neurology, 54, 914-920.
32. Moore, B. D., III, Slopis, J. M., Schomer, D., Jackson, E. F., & Levy, B. M. (1996). Neuropsychological significance of areas of high signal intensity on brain MRIs of children with Neurofibromatosis. Neurology, 46, 1660-1668.
33. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis (1988). Archives of Neurology, 45, 575-578.
34. Noll, R. B., Reiter-Purtill, J., Moore, B. D., Schorry, E. K., Lovell, A. M., Vannatta, K., et al. (2007). Social, emotional, and behavioural functioning of children with NF1. American Journal of Medical Genetics Part A, 143, 2261-2273.
35. Ozonoff, S. (1999). Cognitive impairment in Neurofibromatosis Type 1. American Journal of Medical Genetics, 89, 45-52.
36. Paus, T. (2005). Mapping brain maturation and cognitive development during adolescence. Trends in Cognitive Sciences, 9, 60-68.
37. Polderman, T. J., De Geus, E. J., Hoekstra, R. A., Bartels, M., Van Leeuwen, M., Verhulst, F. C., et al. (2009). Attention problems, inhibitory control, and intelligence index overlapping genetic factors: A study in 9-, 12-, and 18-year-old twins. Neuropsychology, 23, 381-391.
38. Posthuma, D., Luciano, M., De Geus, E. J., Wright, M. J., Slagboom, P. E., Montgomery, G. W., et al. (2005). A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p. American Journal of Human Genetics, 77, 318-326.
39. Reiter-Purttill, J., Schorry, E. K., Lovell, A. M., Vannatta, K., Gerhardt, C. A., & Noll, R. B. (2008). Parental distress, family functioning, and social support in families with and without a child with Neurofibromatosis 1. Journal of Pediatric Psychology, 33, 422-434.
40. Rommelse, N. N. J., Altink, M. E., Martin, N. C., Buschgens, C. J. M., Faraone, S. V., Buitelaar, J. K., et al. (2008). Relationship between endophenotype and phenotype in ADHD. Behavioral and Brain Functions, 4, 4.
41. Rowbotham, I., Pitten Cate, I. M., Sonuga-Barke, E. J. S., & Huijbregts, S. C. J. (2009). Cognitive control in adolescents with Neurofibromatosis Type I. Neuropsychology, 23, 50-60.
42. Schlösser, R., Gesierich, T., Kaufmann, B., Vucurevic, G., Hunsche, S., Gawehn, J., & Stoeter, P. (2003). Altered effective connectivity during working memory performance in schizophrenia: A study with fMRI and structural equation modeling. NeuroImage, 19, 751-763.
43. Schrimsher, G. W., Billingsley, R. L., Slopis, J. M., & Moore, B. D. (2003). Visual-spatial performance deficits as a diagnostic indicator in children with Neurofibromatosis Type-1. American Journal of Medical Genetics A, 120, 326-330.
44. Sergeant, J. A., Geurts, H., Huijbregts, S., Scheres, A., & Oosterlaan, J. (2003). The top and bottom of ADHD: A neuropsychological perspective. Neuroscience and Biobehavioral Reviews, 27, 583-592.
45. Sonuga-Barke, E. J., & Castellanos, F. X. (2007). Spontaneous attentional fluctuations in impaired states and pathological conditions: A neurobiological hypothesis. Neuroscience & Biobehavioral Reviews, 31, 977-986.
46. Witt, S. T., Laird, A. R., & Meyerand, M. E. (2008). Functional neuroimaging correlates of finger-tapping task variations: An ALE meta-analysis. NeuroImage, 42, 343-356.
47. Yurgelun-Todd, D. (2007). Emotional and cognitive changes during adolescence. Current Opinion in Neurobiology, 17, 251-257.
48. Zelazo, P. D., Craik, F. I. M., & Booth, L. (2004). Executive function across the life span. Acta Psychologica, 115, 167-183.